iifl-logo-icon 1

Bajaj Healthcare Ltd Share Price

386.7
(-1.89%)
Jul 12, 2024|03:32:18 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open400
  • Day's High406
  • 52 Wk High513.4
  • Prev. Close394.15
  • Day's Low385
  • 52 Wk Low263.3
  • Turnover (lac)2,524.52
  • P/E37.98
  • Face Value5
  • Book Value102.87
  • EPS10.38
  • Mkt. Cap (Cr.)1,067.23
  • Div. Yield0.25
No Records Found

Bajaj Healthcare Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

400

Prev. Close

394.15

Turnover(Lac.)

2,524.52

Day's High

406

Day's Low

385

52 Week's High

513.4

52 Week's Low

263.3

Book Value

102.87

Face Value

5

Mkt Cap (₹ Cr.)

1,067.23

P/E

37.98

EPS

10.38

Divi. Yield

0.25

Bajaj Healthcare Ltd Corporate Action

8 Sep 2023

12:00 AM

AGM

Announcement Date: 08 Sep, 2023

arrow

30 May 2023

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 23 Sep, 2023

arrow

8 Sep 2023

12:00 AM

BookCloser

arrow

5 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Bajaj Healthcare Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bajaj Healthcare Ltd SHAREHOLDING SNAPSHOT

14 Jul, 2024|07:39 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 67.73%

Foreign: 0.00%

Indian: 67.73%

Non-Promoter- 0.96%

Institutions: 0.96%

Non-Institutions: 31.30%

Custodian: 0.00%

Share Price

Bajaj Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

13.8

13.8

13.8

13.8

Preference Capital

0

0

0

0

Reserves

353.89

314.69

244.61

164.13

Net Worth

367.69

328.49

258.41

177.93

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

656.98

410

370.17

327.1

yoy growth (%)

60.23

10.76

13.16

41.81

Raw materials

-377.89

-263.23

-242.02

-215.28

As % of sales

57.51

64.2

65.38

65.81

Employee costs

-34.54

-28.43

-24.61

-21.65

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

118.81

32.45

24.16

22.68

Depreciation

-16.12

-12.12

-11.41

-11.08

Tax paid

-35.71

-9.95

-7.85

-7.49

Working capital

78.78

14.98

9.66

26.86

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

60.23

10.76

13.16

41.81

Op profit growth

184.93

12.24

8.66

27.97

EBIT growth

226.77

20.85

6.55

39.23

Net profit growth

269.37

37.94

7.4

94.08

View Ratios

No Record found

Bajaj Healthcare Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,581.75

124.473,79,874.71867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,582.5

77.171,21,620.455310.652,259507.93

Cipla Ltd

CIPLA

1,506

32.731,21,596.061,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,163.35

33.971,17,155.821,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,594.75

25.681,10,037.531,034.80.615,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Bajaj Healthcare Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Sanjankumar R Bajaj

Joint Managing Director

Anil C Jain

Whole-time Director

Namrata S Bajaj

Whole-time Director

Dhananjay S Halte

Independent Director

Ram B Banarase

Independent Director

Hemant R Karnik

Company Sec. & Compli. Officer

Aakashkumar Kesari

Independent Director

Loukik D Tipnis

Independent Director

Kejal Shah

Whole-time Director

Pakshal Jain

Whole Time Director

Rupesh H Nikam

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. The Company commenced its operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra. It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities. In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility. In 2013, it set up another API and Intermediate manufacturing plant at Panoli, Ankleshwar and acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November, 2014.In FY 2019-20, the Company acquired Intermediates manufacturing Unit at MIDC, Tarapur Maharashtra and also agreed to acquire Four Manufacturing facilities, comprising of three APIs manufacturing facilities, one Engineering Unit, at MIDC Tarapur, Maharashtra along with an Industrial Plot at Dahej, Gujarat.The Company started commercial operations at Panoli Unit, in Bharuch from May 11, 2022. In 2021-22, it launched a Nutraceutical named Magnesium L-Threonate; commenced commercial production at Tarapur, for Nimesulide API, used for relief from pain and prevention of fe
Read More

Company FAQs

What is the Bajaj Healthcare Ltd share price today?

Down Arrow

The Bajaj Healthcare Ltd shares price on N/A is Rs.₹388 today.

What is the Market Cap of Bajaj Healthcare Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bajaj Healthcare Ltd is ₹1070.82 Cr. as of 12 Jul ‘24

What is the PE and PB ratio of Bajaj Healthcare Ltd?

Down Arrow

The PE and PB ratios of Bajaj Healthcare Ltd is 37.98 and 3.91 as of 12 Jul ‘24

What is the 52 Week High and Low of Bajaj Healthcare Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Bajaj Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bajaj Healthcare Ltd is ₹265 and ₹511 as of 12 Jul ‘24

What is the CAGR of Bajaj Healthcare Ltd?

Down Arrow

Bajaj Healthcare Ltd's CAGR for 5 Years at 30.92%, 3 Years at -6.61%, 1 Year at 27.00%, 6 Month at 6.61%, 3 Month at 21.03% and 1 Month at 27.28%.

What is the shareholding pattern of Bajaj Healthcare Ltd?

Down Arrow

The shareholding pattern of Bajaj Healthcare Ltd is as follows:
Promoters - 67.73 %
Institutions - 0.96 %
Public - 31.30 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.